We are live on ! Find out more
INSM icon

Insmed
INSM

119 hedge funds and large institutions have $1.05B invested in Insmed in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 35

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

3% more funds holding

Funds holding: 116 → 119 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

21% less capital invested

Capital invested by funds: $1.33B → $1.05B (-$275M)

25% less call options, than puts

Call options by funds: $5.7M | Put options by funds: $7.61M

Holders
119
Holders Change
+3
Holders Change %
+2.59%
% of All Funds
3.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
52
Reduced
35
Closed
11
Calls
$5.7M
Puts
$7.61M
Net Calls
-$1.91M
Net Calls Change
-$157K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$35.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$25.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.68M
4
Citigroup
Citigroup
New York
+$9.34M
5
JHIU
Janus Henderson Investors US
Colorado
+$8.75M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$21.8M
2
Millennium Management
Millennium Management
New York
-$17.7M
3
PA
Perceptive Advisors
New York
-$6.98M
4
Citadel Advisors
Citadel Advisors
Florida
-$6.72M
5
Stifel Financial
Stifel Financial
Missouri
-$3.22M

INSM Hedge Fund Activity: Q3 2015 in Review

119 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2015, worth a combined $1.05B — down 21% from $1.33B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new INSM positions and 11 closed out — a net gain of 4 holders — while 52 added to existing stakes and 35 trimmed.

The largest buyer was OrbiMed, adding an estimated $35.9M. The largest seller was Deerfield Management, exiting entirely with an estimated $21.8M sold.

  • 119 institutional investors held Insmed (INSM) as of Q3 2015, up from 116 in Q2 2015.
  • Funds reported $1.05B of Insmed stock for Q3 2015, down 21% quarter-over-quarter.
  • 15 funds opened new Insmed positions in Q3 2015 and 11 closed out, a net change of +4 holders.
  • The largest Insmed buyer in Q3 2015 was OrbiMed, an estimated $35.9M added.
  • The largest Insmed seller in Q3 2015 was Deerfield Management, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2015.